GoingToMeet

There have been significant advances in our understanding of the causes and pathologic progression of neurodegenerative diseases. Identification of disease-causing mutations has provided unprecedented opportunities to develop new and predictive models and move closer to new therapeutic treatments. Technological advances in biochemistry, genomics, proteomics and imaging have facilitated the ability to pose and answer complex questions in complex disease, as well as an appreciation that neurodegenerative diseases have distinct cell death signaling cascades that can share some common molecular events. In this meeting an emphasis will be placed on understanding mechanisms that may be common and those that are distinct in neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), triple repeat diseases, amyotrophic lateral sclerosis (ALS) and others.